EMF-Portal | 文献検索結果

2017, Lu M, Ueno S

Safety assessment of ultra-high voltage transmission power lines with AC-750 kV [tech./dosim.]

2017 XXXIInd General Assembly and Scientific Symposium of the International Union of Radio Science (URSI GASS), Montreal, QC, Canada. IEEE: pp. 1-3; ISBN 978-90-825987-0-4

2017, Sharma A, Kesari KK, Verma HN, Sisodia R

Neurophysiological and Behavioral Dysfunctions After Electromagnetic Field Exposure: A Dose Response Relationship [basics]

Perspectives in Environmental Toxicology. Springer: pp. 1-30; ISBN 978-3-319-46247-9

2017, Okano H, Osuga T, Ansei Y, Hattori Y, Tatsuoka H

The Effects of Moderate-Intensity Inhomogeneous Static Magnetic Fields on Neuromuscular Transmission [med./bio.]

NNOA 2 (3): 000126

2017, Mehta V, Snidvongs S, Ghai B, Langford R, Wodehouse T

Characterization of peripheral and central sensitization after dorsal root ganglion intervention in patients with unilateral lumbosacral radicular pain: a prospective pilot study [med. app.]

Br J Anaesth 118 (6): 924-931

2017, Fouillet A, Watson JF, Piekarz AD, Huang X, Li B, Priest B, Nisenbaum E, Sher E, Ursu D

[電界刺激アッセイを用いたラットの後根神経節ニューロンにおけるNav1.7の機能的発現の特徴付け] [med./bio.]

Mol Pain 13: 1744806917745179

2017, Deniz OG, Kaplan S, Selçuk MB, Terzi M, Altun G, Yurt KK, Aslan K, Davis D

Effects of short and long term electromagnetic fields exposure on the human hippocampus [med./bio.]

J Microsc Ultrastruct 5 (4): 191-197

2017, Altun G, Kaplan S, Deniz OG, Kocacan SE, Canan S, Davis D, Marangoz C

Protective effects of melatonin and omega-3 on the hippocampus and the cerebellum of adult Wistar albino rats exposed to electromagnetic fields [med./bio.]

J Microsc Ultrastruct 5 (4): 230-241

2017, Tran MTD, Skovbjerg S, Arendt-Nielsen L, Bech P, Lunde M, Elberling J

[多種化学物質過敏症を呈する患者三人のうち二人はパルス化電磁界の経頭蓋的適用後の症状及び二次痛覚過敏がより少ない] [med. app.]

Scand J Pain 5 (2): 104-109

2017, Schmid G, Hirtl R, Schneeweiß P, Jhala T, Sainitzer D

[FV 3609S80002からのRFID技術へのばく露についてのデータの補足分析及び商品監視装置についての調査‐プロジェクト3612S80004] [info]

Federal Office for Radiation Protection (BfS), Ressortforschungsberichte zur kerntechnischen Sicherheit und zum Strahlenschutz, BfS-RESFOR-92/14: 1-114

2017, Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran DD, Brem S, Hottinger AF, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Burna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z

[神経膠芽腫の患者における生存率に対するTumor Treating Field［腫瘍治療装置の名称］＋テモゾロミド対テモゾロミド単独の効果：無作為化臨床試験] [med. app.]

JAMA 318 (23): 2306-2316